Known as skin whitening or brightening drips, the treatments contain the antioxidant glutathione, which has skin-lightening effects.

Exposing dangerous glutathione ‘skin whitening’ IV drips in UK By Cherise Hamilton Stephenson A new IV drip claiming to whiten or lighten skin is rapidly gaining popularity, but at what cost?

In the most recent trading session, Vistra Corp. (VST) closed at $185.10, indicating a +2.19% shift from the previous trading day.

Vistra is surging on AI-driven power demand, clean energy growth, and strong financials, with more upside ahead. See why VST stock is a strong buy.

Vistra announced plans to acquire seven natural gas-fired power plants from Lotus Infrastructure Partners. The acquisition, totaling 2,600 megawatts (MW), includes five combined-cycle plants and ...

Rather than guiding on revenue or earnings, Vistra gives guidance in the very company-specific formats of "ongoing operations adjusted EBITDA (earnings before interest, taxes, depreciation, and ...

There was substantially more insider selling, than buying, of Vistra shares over the last three months. In total, Independent Director Paul Barbas sold US$6.0m worth of shares in that time.

Skin brightening is about increasing your skin’s radiance and evening out your skin tone without altering your natural complexion. It’s the safest and most skin-friendly approach.

Experts explain how exosomes skin care works, and how they can be incorporated topically into your routine to make skin look healthier, smoother, and brighter.

The government in Nigeria is warning about the health risks of skin lightening, where potent chemicals can thin and damage skin. It's a booming business in that country and others.

Despite Vistra's recent underperformance relative to the S&P 500, Wall Street analysts remain highly optimistic about the stock’s prospects.